Metabolic Diseases Drug Discovery-Strategic Research Institute's Third International World Summit. PPAR and PTB1B modulators 26-27 July 2004, San Diego, CA, USA.
Xu
Jing
J
BioMinerva Group, 11553 Hadar Drive, San Diego, CA 92126, USA. jxu4@san.rr.com
D000047:Academies and Institutes; D000818:Animals; D016503:Drug Delivery Systems; D015195:Drug Design; D004345:Drug Industry; D006801:Humans; D038622:Internationality; D008659:Metabolic Diseases / Q000188:drug therapy*; D016376:Oligonucleotides, Antisense; D047492:Peroxisome Proliferator-Activated Receptors / Q000819:agonists / Q000037:antagonists & inhibitors; D047428:Protein Kinase Inhibitors; D054562:Protein Tyrosine Phosphatase, Non-Receptor Type 1; D017027:Protein Tyrosine Phosphatases / Q000037:antagonists & inhibitors; D034741:RNA, Small Interfering
D016376:Oligonucleotides, Antisense; D047492:Peroxisome Proliferator-Activated Receptors; D047428:Protein Kinase Inhibitors; D034741:RNA, Small Interfering; C516607:PTPN1 protein, human; D054562:Protein Tyrosine Phosphatase, Non-Receptor Type 1; D017027:Protein Tyrosine Phosphatases